Evidence & RegulatoryMedia & AwardsInsightsOrthoHeal AcademyInvestorsCareersContact

Home / Investors

Plaster has held bones since 1852. We built what comes next.

OrthoHeal makes FlexiOH® — a light-cured polymer immobilizer that is washable, breathable and removed without a saw. Invented by a surgeon, manufactured in Gujarat, used in more than fifty countries.

Why now

The most common injury in medicine, treated with a nineteenth-century bandage

  • 178 million new fractures a year. 455 million people are living with the acute or long-term symptoms of one, costing 25.8 million years lived with disability. Global Burden of Disease Study 2019, Lancet Healthy Longevity.
  • The standard of care is 174 years old. Antonius Mathijsen introduced the plaster-of-Paris bandage in 1852. It cannot get wet, it does not breathe, and it is removed with an oscillating saw.
  • Fibreglass and thermoplastics changed the material, not the experience. Still not washable, still not breathable, still cut off.
  • The cost is borne twice. Once by the patient — six weeks of itching, odour and washing around a limb — and once by the department, in saw time, saw injuries and re-casting.

The fracture-burden paper and our clinical evidence →

178M

new fractures a year

worldwide, GBD 2019

455M

people living with one

acute or long-term symptoms

Why it has not been solved

A better cast has to be rigid enough to hold a reduction, soft enough to mould onto a limb, safe against skin, and quick enough — under fifteen minutes — to fit a routine workflow. Materials that do one tend to fail another. FlexiOH® cures under visible blue light, so it is soft when it goes on and rigid a few minutes later — the shape is locked to the reduction the surgeon achieved.

What we built

A platform, not a product

One curing technology, four product families, and an installed light in every cast room that uses them.

The technology

Light-cured polymer

A photo-curing resin sealed in silicone over a latex-free foam liner. Soft on the limb; rigid in three to five minutes under RizyCure's UV-free blue light. Washable, breathable, and removed with bone-cutting forceps — no saw, no dust, no noise.

The razor and the blade

Equipment pulls consumable

One RizyCure light is installed in the cast room; the immobilizers are single-use and reorder themselves. The light is what gets a department to try the system — the consumable is what makes it a business.

The range

Four families

FlexiSplint® for urgent and post-operative care, FlexiOH® for conservative fracture management, FlexiCast® for remouldable casting, and FlexiBrace® for rehabilitation from Q4 2027 — across upper and lower limb, adult and paediatric.

Unboxing to cured, in 46 seconds. Sizing, zipping and curing under the RizyCure light.

What is defensible

  • Patented light-cured polymer chemistry, developed in-house
  • Exclusive licence to commercialise FlexiOH from the Government of India
  • Vertically integrated manufacturing — resin, lattice and assembly under one roof
  • Regulatory files already cleared in ten jurisdictions, each one a barrier behind us and in front of a follower
Where we are

Shipping, cleared, and manufacturing at scale

200,000+

immobilizers on patients

since commercial launch in 2020

50+

countries served

from offices in Vadodara, Hamburg and Texas

125,000 sq ft

manufacturing at Savli

occupied January 2025, scaling towards a million units a year

Regulatory position

ISO 13485:2016 · BSICE · EU MDRUS FDA listedCDSCOSFDATGANIDSTFDAMOHAPDMEHW

Registration or listing with a regulator is not approval, clearance or endorsement. FlexiOH® is "US FDA listed"; CE marking is by declaration of conformity as a Class I device. Certificates and status by market →

Clinical evidence

  • 108-patient retrospective cohort, 2026. Alignment at device removal was anatomic or near-anatomic in 103 of 104 fractures — 99.1%.
  • Five-site Indian post-market study. 137 distal radius fractures; radiographic healing seen in all participants.
  • National BioPharma Mission grant with BIRAC, for trials establishing equivalence with gold-standard immobilisation.

Read the papers →

Recognition

A decade of grants and national recognition

  1. 2015

    BIRAC–SRISTI Gandhian Young Technological Innovation Award, presented at Rashtrapati Bhavan. Exclusive licence to commercialise FlexiOH® from the Government of India.

  2. 2016

    Gold medal, Top 50 Innovations — DST–Lockheed Martin India Innovation Growth Programme. BIRAC Biotechnology Ignition Grant. CII Industrial Innovation Awards, Top 10 Promising Start-ups.

  3. 2018

    BIRAC Biotechnology Industry Partnership Programme grant for pilot-scale production.

  4. 2022

    Grand Challenges India grant, sponsored by the Bill & Melinda Gates Foundation, for paediatric deformity work.

  5. 2023

    National Startup Awards 2022 — winner, Health & Wellness. ISO 13485:2016 certification by BSI.

  6. 2024

    Ubharte Sitare export champions programme. SFDA registration, Saudi Arabia.

The OrthoHeal manufacturing facility at Savli, Gujarat

Who runs it

A brilliant team led by the founder — a physician-engineer with an MBBS and an MMST from IIT Kharagpur, who invented FlexiOH during the Stanford India Biodesign fellowship at AIIMS Delhi. The advisory bench includes that fellowship's director, an AIIMS orthopaedic spine surgeon, an IIT Delhi design professor, and a former president of Tata AutoComp Systems.

Leadership and advisors

Request the investor deck

Tell us who you are and what you would like to see. We reply from the founder's office, usually within two working days.

Rather see it first?

The technology page explains how the polymer cures; the evidence page holds every certificate and paper.

WhatsApp enquiry